The overexpression of FOXA1 was inversely correlated with IFN signaling activity and antigen-presenting gene expression in prostate cancer patients, contributing to immune escape and conferring resistance to immune checkpoint inhibitors [116]. The gene discussed is IFNA1; the disease is prostate cancer.